EXAS - Exact Sciences Corporation

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
12.97B
Enterprise Value 3
11.11B
Trailing P/E
N/A
Forward P/E 1
-259.00
PEG Ratio (5 yr expected) 1
-2.72
Price/Sales (ttm)
17.92
Price/Book (mrq)
15.28
Enterprise Value/Revenue 3
15.35
Enterprise Value/EBITDA 6
-75.71

Trading Information

Stock Price History

Beta (5Y Monthly) 1.35
52-Week Change 318.02%
S&P500 52-Week Change 325.98%
52 Week High 3123.99
52 Week Low 375.35
50-Day Moving Average 391.80
200-Day Moving Average 3100.13

Share Statistics

Avg Vol (3 month) 32.32M
Avg Vol (10 day) 33.74M
Shares Outstanding 5129.83M
Float 128.13M
% Held by Insiders 11.20%
% Held by Institutions 180.28%
Shares Short (Dec 30, 2019) 414.38M
Short Ratio (Dec 30, 2019) 48.07
Short % of Float (Dec 30, 2019) 411.28%
Short % of Shares Outstanding (Dec 30, 2019) 49.77%
Shares Short (prior month Nov 28, 2019) 412.68M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2018
Most Recent Quarter (mrq)Sep 29, 2019

Profitability

Profit Margin -29.83%
Operating Margin (ttm)-24.57%

Management Effectiveness

Return on Assets (ttm)-6.80%
Return on Equity (ttm)-29.48%

Income Statement

Revenue (ttm)723.7M
Revenue Per Share (ttm)5.70
Quarterly Revenue Growth (yoy)85.00%
Gross Profit (ttm)336.48M
EBITDA -146.73M
Net Income Avi to Common (ttm)-215.91M
Diluted EPS (ttm)-1.70
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.16B
Total Cash Per Share (mrq)8.94
Total Debt (mrq)836.71M
Total Debt/Equity (mrq)111.82
Current Ratio (mrq)2.75
Book Value Per Share (mrq)5.76

Cash Flow Statement

Operating Cash Flow (ttm)-87.56M
Levered Free Cash Flow (ttm)-186.2M